Outsource the burden of identifying rebates with the Lyfegen rebate analytics service (RETRO) for risk-free analysis and assurance that each rebate is fully captured, valid, and accurate.
Only a small amount of your time is needed for Lyfegen to conduct a retrospective analysis.
With minimal set-up time required, free up your time and resource by outsourcing retrospective rebate analysis to us so that we can identify unclaimed rebates and increase your savings.
The Lyfegen RETRO service is completely risk-free, with no upfront costs.
The Lyfegen retrospective analysis is a risk-free service, and Lyfegen only gets reimbursed if we identify any unclaimed rebates.
Identify unclaimed rebates and ensure contract compliance
Unclaimed rebates can be as high as 10-15% of total rebates. On average, Lyfegen identifies 10-100% of unclaimed rebates. With the Lyfegen RETRO, you can rest-assured that no rebate is left unclaimed.
01
Minimal time investment
Only a small amount of your time is needed for Lyfegen to conduct a retrospective analysis.
With minimal set-up time required, free up your time and resource by outsourcing retrospective rebate analysis to us so that we can identify unclaimed rebates and increase your savings.
02
Risk free
The Lyfegen RETRO service is completely risk-free, with no upfront costs.
The Lyfegen retrospective analysis is a risk-free service, and Lyfegen only gets reimbursed if we identify any unclaimed rebates.
03
Increase rebates
Identify unclaimed rebates and ensure contract compliance
Lorem ipsum dolor sit amet, consectet adipiscing elit. Arcu elementum tellus purus, consectetur ultricies arcu leo. Lorem ipsum dolor sit amet, consectet adipiscing elit. Arcu elementum tellus purus, consectetur ultricies arcu leo.
Minimal time investment
Risk free
Increase rebates
Benefit from a fully transparent service
Dedicated support & industry expertise
Lorem Ipsum
Rum qui blaccum quiatur, quaes es ad ex et enihit, tem am eius et re doluptate. Rum qui blaccum quiatur, quaes es ad ex et enihit, tem.
Lorem Ipsum
Rum qui blaccum quiatur, quaes es ad ex et enihit, tem am eius et re doluptate. Rum qui blaccum quiatur, quaes es ad ex et enihit, tem.
Lorem Ipsum
Rum qui blaccum quiatur, quaes es ad ex et enihit, tem am eius et re doluptate. Rum qui blaccum quiatur, quaes es ad ex et enihit, tem.
Lorem Ipsum
Rum qui blaccum quiatur, quaes es ad ex et enihit, tem am eius et re doluptate. Rum qui blaccum quiatur, quaes es ad ex et enihit, tem.
Lorem Ipsum
Rum qui blaccum quiatur, quaes es ad ex et enihit, tem am eius et re doluptate. Rum qui blaccum quiatur, quaes es ad ex et enihit, tem.
Lorem Ipsum
Rum qui blaccum quiatur, quaes es ad ex et enihit, tem am eius et re doluptate. Rum qui blaccum quiatur, quaes es ad ex et enihit, tem.
Lorem Ipsum
Rum qui blaccum quiatur, quaes es ad ex et enihit, tem am eius et re doluptate. Rum qui blaccum quiatur, quaes es ad ex et enihit, tem.
Lorem Ipsum
Rum qui blaccum quiatur, quaes es ad ex et enihit, tem am eius et re doluptate. Rum qui blaccum quiatur, quaes es ad ex et enihit, tem.
The risk-free Lyfegen retrospective analysis identifies any unclaimed drug rebates for you to increase your savings. The increasing number and complexity of drug rebate agreements and the manual process of identifying these rebates often leads to unclaimed rebates. On average, these unclaimed rebates can be as high as 10-15% of total rebates. The Lyfegen retrospective analysis is risk-free and Lyfegen is only reimbursed if we identify any unclaimed rebates.
Existing and proven solution.
Easy and fast to implement.
Minimal time investment.
Save costs.
We will respond within the next 24 hours.
* By sending this message, you agree to our privacy policy.